Speech Production Enhancement Using Augmentative Communication for Kids
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age7-17
SponsorUniversity of Wisconsin, Madison
About this trial
The goal of this clinical trial is to learn if speech supplementation can improve speech intelligibility in children ages 7 to 17 years with cerebral palsy. The main questions it aims to answer are:
* To what extent can speech supplementation improve intelligibility in children with CP compared with habitual speech produced without speech supplementation? * How much intelligibility change is necessary for meaningful improvement when children use speech supplementation strategies?
Participants will:
* complete speech and language assessments * complete a speech pre-test using habitual speech * learn a speech supplementation strategy with training from a speech-language pathologist * complete a speech post-test using the speech supplementation strategy * complete a speech repetition task where specific words are emphasized (emphatic stress) * use the previously learned speech supplementation strategy + emphasis on specific words while producing a set of sentences
Eligibility criteria
Qualifiers
Medical diagnosis of cerebral palsy, or a similar, related condition that affects early motor development and presents as a chronic motor disability
Age between 7 and 17 years
Clinical dysarthria with speech intelligibility between 10-85 percent
Able to produce connected speech in English, with a minimum utterance length of 3 words
Disqualifiers
Failure to meet all inclusion criteria.
Vision impairment that precludes being able to see items on a communication board.
Not suitable for participation due to other reasons at the discretion of the investigators.
Trial design
Treatments tested in this trial
- AAC Speech supplementation
Treatment groups
100 Participants
are divided into 1 treatment groupSponsors and collaborators
University of Wisconsin, Madison
Lead sponsor
National Institute on Deafness and Other Communication Disorders (NIDCD)
Collaborator
Source ClinicalTrials.gov